The COVID-19 biorepository and comprehensive database have been created to accelerate a wide variety of research efforts including characterizing the basic pathophysiology of the disease, its clinical outcomes as well as the development of diagnostic tests, vaccines and treatments.
We spoke with Amanda Vest, MD from the CardioVascular Center at Tufts Medical Center about what doctors have learned so far about the connection between COVID-19 and pre-existing heart conditions.
When Frank Basler, 58, and his son were in Killington, VT at a bachelor party in March 2020 their only concern was having a good time. The expectant grandfather was enjoying spending time with his son and their friends in the mountains of Vermont. Nine days later, Frank was on a ventilator fighting to breathe.
Our number one priority is the health and safety of our patients, employees and clinicians. That is why today we are announcing that we will require those who work within our hospitals and health system to be vaccinated against COVID-19 following the full FDA approval of one of the current vaccines. We anticipate this happening later this year.
Your initial vaccination offers strong protection against the COVID-19 virus, and are working well to prevent severe illness, hospitalization and death, even against the widely circulating Delta variant. However, public health experts are starting to see reduced protection, especially among certain populations, against mild and moderate disease.
New England Comprehensive Stroke Center (CSC) Collaborative, created by Tufts Medical Center, is signing a pledge to continue providing care for stroke patients.
On August 13, 2021 the Centers for Disease Control and Prevention (CDC) provided new recommendations for the mRNA (Pfizer and Moderna) COVID-19 vaccines for moderately to severely immunocompromised people. The CDC now recommends a third dose of the Pfizer or Moderna COVID-19 vaccine for these individuals.
While lifting restrictions is great news, for many eager young athletes, there is a concern of injuries from lack of organized practice and team sports during the COVID-19 pandemic.
In collaboration with Chelmsford Emergency Management and the City of Lowell, Lowell General Hospital will set up a tent at its Saints campus this weekend to accommodate additional testing when more tests become available.
MIRI PI Dr. Michael House and his team members received a COVID-19 Rapid Response SeeD Funding Grant. This new funding program is intended to fast track innovative research proposals that directly address the urgent needs of the COVID-19 pandemic.
Today the Centers for Disease Control and Prevention (CDC), U.S. Federal Drug Administration (FDA) and Massachusetts Department of Public Health directed providers to pause the administration of the Johnson & Johnson (Janssen) COVID-19 vaccine as they investigate reports of blood clots in six women who received the J&J vaccine. None of these cases appear to have occurred in Massachusetts.
MelroseWakefield Hospital began administering the second round of COVID-19 vaccines earlier last week, 21 days after frontline workers received the first dose.
It was your average Sunday evening. Nine-month-old Neela and her mom and dad were spending a quiet night at home. Mom was feeding Neela scrambled eggs for the first time, when almost immediately, Neela’s lips started to swell. Mom and Dad suspected an allergic reaction but took to Google and a phone call to their pediatrician to confirm. Even though the swelling started to subside after a few minutes, Neela’s on-call doctor recommended a trip to the Emergency Room, just to be safe.